RedHill Announces Positive Obesity and Diabetes Results with Opaganib

Go back to RedHill Announces Positive Obesity and Diabetes Results with Opaganib
REDHILL BIO SP ADS (NASDAQ: RDHL) Delayed: 0.50 -0.02 (3.85%)
Previous Close $0.52    52 Week High $16.54 
Open $0.53    52 Week Low $8.10 
Day High $0.53    P/E N/A 
Day Low $0.50    EPS $0.00 
Volume 102,859